An American Sickness: How Healthcare Became Big Business and How You Can Take It Back

by Elisabeth Rosenthal

This practice of comparing new drugs with placebos rather than other currently available treatments as a criterion for licensing has also led to both a plethora of expensive me-too drugs and a dearth of trials and published efficacy studies.